Cargando…
A multi-antigen vaccine in combination with an immunotoxin targeting tumor-associated fibroblast for treating murine melanoma
A therapeutically effective cancer vaccine must generate potent antitumor immune responses and be able to overcome tolerance mechanisms mediated by the progressing tumor itself. Previous studies showed that glycoprotein 100 (gp100), tyrosinase-related protein 1 (TRP1), and tyrosinase-related protein...
Autores principales: | Fang, Jinxu, Hu, Biliang, Li, Si, Zhang, Chupei, Liu, Yarong, Wang, Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824564/ https://www.ncbi.nlm.nih.gov/pubmed/27119119 http://dx.doi.org/10.1038/mto.2016.7 |
Ejemplares similares
-
In Situ Modulation of Dendritic Cells by Injectable
Thermosensitive Hydrogels for Cancer Vaccines in Mice
por: Liu, Yarong, et al.
Publicado: (2014) -
Synergistic immunotoxin-paclitaxel combination against lymphoma
por: Müller, Fabian
Publicado: (2017) -
Immunotoxins: experimental design
por: Dall, P, et al.
Publicado: (2001) -
Immunotoxins: The Role of the Toxin (†)
por: Antignani, Antonella, et al.
Publicado: (2013) -
Countering immunotoxin immunogenicity
por: Flavell, David J
Publicado: (2016)